Li Zonghai - Net Worth and Insider Trading
Li Zonghai Net Worth
The estimated net worth of Li Zonghai is at least $677 Million dollars as of 2024-09-13. Li Zonghai is the 2401 A concert party to an agreement to buy shares of CARsgen Therapeutics Holdings Ltd and owns about 217,026,230 shares of CARsgen Therapeutics Holdings Ltd (HKSE:02171) stock worth over $677 Million. Details can be seen in Li Zonghai's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Li Zonghai has not made any transactions after 2024-06-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Li Zonghai
Li Zonghai Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Li Zonghai owns 1 companies in total, including CARsgen Therapeutics Holdings Ltd (HKSE:02171) .
Click here to see the complete history of Li Zonghai’s form 4 insider trades.
Insider Ownership Summary of Li Zonghai
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HKSE:02171 | CARsgen Therapeutics Holdings Ltd | 2024-06-05 | 2401 A concert party to an agreement to buy shares |
Li Zonghai Latest Holdings Summary
Li Zonghai currently owns a total of 1 stock. Li Zonghai owns 217,026,230 shares of CARsgen Therapeutics Holdings Ltd (HKSE:02171) as of June 4, 2024, with a value of $677 Million.
Latest Holdings of Li Zonghai
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HKSE:02171 | CARsgen Therapeutics Holdings Ltd | 2024-06-04 | 217,026,230 | 3.12 | 677,121,838 |
Holding Weightings of Li Zonghai
Li Zonghai Form 4 Trading Tracker
According to the SEC Form 4 filings, Li Zonghai has made a total of 6 transactions in CARsgen Therapeutics Holdings Ltd (HKSE:02171) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in CARsgen Therapeutics Holdings Ltd is the sale of 200,000 shares on June 4, 2024, which brought Li Zonghai around $0.
Insider Trading History of Li Zonghai
- 1
Li Zonghai Trading Performance
Li Zonghai Ownership Network
Li Zonghai Owned Company Details
What does CARsgen Therapeutics Holdings Ltd do?
Who are the key executives at CARsgen Therapeutics Holdings Ltd?
Li Zonghai is the 2401 A concert party to an agreement to buy shares of CARsgen Therapeutics Holdings Ltd. Other key executives at CARsgen Therapeutics Holdings Ltd include 2401 A concert party to an agreement to buy shares Guo Bingsen , 2101 Beneficial owner Guo Huaqing , and 2401 A concert party to an agreement to buy shares Wang Huamao .
CARsgen Therapeutics Holdings Ltd (HKSE:02171) Insider Trades Summary
Over the past 18 months, Li Zonghai made 5 insider transaction in CARsgen Therapeutics Holdings Ltd (HKSE:02171) with a net sale of 0. Other recent insider transactions involving CARsgen Therapeutics Holdings Ltd (HKSE:02171) include a net purchase of 1,369,500 shares made by Guo Huaqing , a net sale of 0 shares made by Wang Huamao , and a net sale of 0 shares made by Guo Bingsen .
In summary, during the past 3 months, insiders sold 0 shares of CARsgen Therapeutics Holdings Ltd (HKSE:02171) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of CARsgen Therapeutics Holdings Ltd (HKSE:02171) were sold and 1,369,500 shares were bought by its insiders, resulting in a net purchase of 1,369,500 shares.
CARsgen Therapeutics Holdings Ltd (HKSE:02171)'s detailed insider trading history can be found in Insider Trading Tracker table.
CARsgen Therapeutics Holdings Ltd Insider Transactions
Li Zonghai Mailing Address
Above is the net worth, insider trading, and ownership report for Li Zonghai. Currently GuruFocus does not have mailing address information for Li Zonghai.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
